Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study
Submitted: 20 February 2016
Accepted: 1 August 2016
Published: 9 September 2016
Accepted: 1 August 2016
Abstract Views: 2152
PDF: 1313
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- A. Alunno, O. Bistoni, F. Pratesi, F. Topini, I. Puxeddu, V. Valentini, G. Cafaro, E. Bartoloni, P. Migliorini, R. Gerli, Association between anti-citrullinated alpha enolase antibodies and clinical features in a cohort of patients with rheumatoid arthritis: a pilot study , Reumatismo: Vol. 70 No. 2 (2018)
- M. A. Marie, R. E. Abu Khalil, H. M. Habib, Urinary CXCL10: a marker of nephritis in lupus patients , Reumatismo: Vol. 65 No. 6 (2013)
- M. Lorenzin, A. Ortolan, P. Frallonardo, S. Vio, C. Lacognata, F. Oliviero, L. Punzi, R. Ramonda, Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study , Reumatismo: Vol. 68 No. 2 (2016)
- C. Chatzigeorgiou, S.L. Mackie, Comorbidity in polymyalgia rheumatica , Reumatismo: Vol. 70 No. 1 (2018): Monographic issue on Polymyalgia Rheumatica
- A. Alunno, G. Nocentini, O. Bistoni, M.G. Petrillo, E. Bartoloni Bocci, S. Ronchetti, E. Lo Vaglio, C. Riccardi, R. Gerli, Expansion of CD4+CD25-GITR+ regulatory T-cell subset in the peripheral blood of patients with primary Sjögren's syndrome: correlation with disease activity , Reumatismo: Vol. 64 No. 5 (2012)
- C. Garufi, S. Mancuso, F. Ceccarelli, L. Caruso, C. Alessandri, M. Di Franco, R. Priori, V. Riccieri, R. Scrivo, S. Truglia, F. Conti, F.R. Spinelli, PASSing to the patient side: early achieving of an acceptable symptom state in patients with rheumatoid arthritis treated with Janus kinase inhibitors , Reumatismo: Early Access
- K. El-Hadidi, S.M. Gamal, S. Saad, N.Y. Elsaid, Is CDAI comparable to DAS 28 and SDAI regarding inter-observer agreement and correlation to MHAQ in Egyptian RA patients? , Reumatismo: Vol. 71 No. 4 (2019)
- N. Belfeki, M. Smiti Khanfir, F. Said, A. Hamzaoui, T. Ben Salem, I. Ben Ghorbel, M. Lamloum, M.H. Houman, Successful treatment of refractory adult onset Still’s disease with rituximab , Reumatismo: Vol. 68 No. 3 (2016)
- F. Atzeni, M. Turiel, L. Boccassini, S. Sitia, L. Tomasoni, M. Battellino, A. Marchesoni, V. De Gennaro Colonna, P. Sarzi-Puttini, Cardiovascular involvement in psoriatic arthritis , Reumatismo: Vol. 63 No. 3 (2011)
- M. E. Tezcan, Ş. Demir, M. Sargın, M. Aliustaoğlu, B. Göker, Sjögren’s syndrome and mean platelet volume , Reumatismo: Vol. 67 No. 1 (2015)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
You may also start an advanced similarity search for this article.